SEC registrant · CIK 0001388320

Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals, Inc. (CIK 0001388320, ticker ATNM, EIN 88-0378336) reported revenue of $90,000 for FY2025 (2025-01-01 to 2025-12-31) and net income of -$33.89 million (-$33,887,000) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2026-03-30 (accession 0001213900-26-036504).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001388320
TickersATNM (NYSE)
EIN88-0378336
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_4t18wgj1eag4kcmcfezfy134xw
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$90,000FY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036504Revenues
Net income-$33,887,000FY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036504NetIncomeLoss
Total assets$51,775,000FY2025as of 2025-12-3110-K2026-03-300001213900-26-036504Assets
Total liabilities$43,941,000FY2025as of 2025-12-3110-K2026-03-300001213900-26-036504Liabilities
Stockholders' equity$7,834,000FY2025as of 2025-12-3110-K2026-03-300001213900-26-036504StockholdersEquity
Operating cash flow-$24,580,000FY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036504NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$1.09 per shareFY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036504EarningsPerShareDiluted
Shares outstanding31,374,994 sharesFY2025as of 2026-03-3010-K2026-03-300001213900-26-036504EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252025-01-01 to 2025-12-31$90,00010-K2026-03-300001213900-26-036504
RevenueFY20232023-01-01 to 2023-12-31$81,00010-K2025-03-310001213900-25-026371
RevenueFY20222022-01-01 to 2022-12-31$1,030,00010-K2024-03-290001213900-24-028038
RevenueFY20212021-01-01 to 2021-12-31$1,144,00010-K2023-03-310001213900-23-025597
Net incomeFY20252025-01-01 to 2025-12-31-$33,887,00010-K2026-03-300001213900-26-036504
Net incomeFY20242024-01-01 to 2024-12-31-$38,243,00010-K2026-03-300001213900-26-036504
Net incomeFY20232023-01-01 to 2023-12-31-$48,818,00010-K2025-03-310001213900-25-026371
Net incomeFY20222022-01-01 to 2022-12-31-$33,017,00010-K2024-03-290001213900-24-028038
Net incomeFY20212021-01-01 to 2021-12-31-$24,774,00010-K2023-03-310001213900-23-025597
Net incomeFY20202020-01-01 to 2020-12-31-$22,215,00010-K2022-03-250001213900-22-015208
Net incomeFY20192019-01-01 to 2019-12-31-$21,900,00010-K2021-03-310001213900-21-019297
Net incomeFY20182018-01-01 to 2018-12-31-$23,653,96310-K2020-05-080001213900-20-011475
Net incomeFY20172017-01-01 to 2017-12-31-$26,601,23510-K2019-03-150001213900-19-004269
Net incomeFY20162016-01-01 to 2016-12-31-$24,321,72410-K2019-03-150001213900-19-004269
  • Net income for FY2019 was restated: first reported as -$21,899,054 (accession 0001213900-20-011475, filed 2020-05-08).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001388320published by the sourcedata.sec.gov/submissions/CIK0001388320.json2026-10-21
Employer Identification Number (EIN) · US-EIN88-0378336published by the sourcedata.sec.gov/submissions/CIK0001388320.json2026-10-21

Former names

NameFromTo
Cactus Ventures, Inc.2007-02-052013-03-29

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001388320.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001388320.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001388320" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001388320/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001388320/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1388320"}

On SEC EDGAR

About this data